(Q42609563)

3 November 2017

title

Perospirone in the treatment of patients with delirium (English)

1 reference

3 November 2017

Takashi Takeuchi

1

1 reference

3 November 2017

Ko Furuta

2

1 reference

3 November 2017

Toshiyuki Hirasawa

3

1 reference

3 November 2017

Hidekazu Masaki

4

1 reference

3 November 2017

Tomoaki Yukizane

5

1 reference

3 November 2017

Hidenori Atsuta

6

1 reference

3 November 2017

Toru Nishikawa

7

1 reference

3 November 2017

publication date

1 February 2007

1 reference

Psychiatry and Clinical Neurosciences

3 November 2017

published in

1 reference

3 November 2017

volume

61

1 reference

3 November 2017

issue

1

1 reference

3 November 2017

page(s)

67-70

1 reference

Science is revolutionizing our view of addiction--and what to do about it.

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

A double-blind trial of risperidone and haloperidol for the treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Treatment for delirium with risperidone: results of a prospective open trial with 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Efficacy of risperidone in treating the hyperactive symptoms of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Use of risperidone in delirium: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Treatment of delirium in older adults with quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

A pilot trial of quetiapine for the treatment of patients with delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Use of quetiapine in delirium: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Treatment of Delirium With Quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Quetiapine for treatment-resistant delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

An open pilot trial of olanzapine for delirium in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Olanzapine vs haloperidol: treating delirium in a critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

The role of atypical antipsychotics in the treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2007.01612.X

10.1111/J.1440-1819.2007.01612.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference